These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 28245508)
1. Immunohistochemical Expression of the Tumor Suppressor Protein p16INK4a in Cervical Adenocarcinoma. Eleutério J; Lima TS; Cunha MD; Cavalcante DI; Silva AM Rev Bras Ginecol Obstet; 2017 Jan; 39(1):21-25. PubMed ID: 28245508 [No Abstract] [Full Text] [Related]
2. Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia. Tringler B; Gup CJ; Singh M; Groshong S; Shroyer AL; Heinz DE; Shroyer KR Hum Pathol; 2004 Jun; 35(6):689-96. PubMed ID: 15188135 [TBL] [Abstract][Full Text] [Related]
3. P16(INK4a) protein expression in endocervical, endometrial and metastatic adenocarcinomas of extra-uterine origin: diagnostic and clinical considerations. Caponio MA; Addati T; Popescu O; Petroni S; Rubini V; Centrone M; Trojano G; Simone G Cancer Biomark; 2014; 14(2-3):169-75. PubMed ID: 24878818 [TBL] [Abstract][Full Text] [Related]
4. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas. Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536 [TBL] [Abstract][Full Text] [Related]
5. [Evaluation of level of expression of p16 (INK4a) in endocervical lesions of uterine cervix]. Popovska S; Betova T; Tomov S; Gorchev G; Dikov T Akush Ginekol (Sofiia); 2005; 44(5):9-13. PubMed ID: 16313047 [TBL] [Abstract][Full Text] [Related]
6. Research on expression and importance of p53, p16 and VEGF-C in cervical cancer. Cai S; Han K J Gynecol Obstet Biol Reprod (Paris); 2015 Sep; 44(7):639-45. PubMed ID: 25443468 [TBL] [Abstract][Full Text] [Related]
7. p16INK4A overexpression in precancerous and cancerous lesions of the uterine cervix in Tunisian women. Missaoui N; Trabelsi A; Hmissa S; Fontanière B; Yacoubi MT; Mokni M; Korbi S; Frappart L Pathol Res Pract; 2010 Aug; 206(8):550-5. PubMed ID: 20400236 [TBL] [Abstract][Full Text] [Related]
8. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2. McCluggage WG; Shah R; Connolly LE; McBride HA Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982 [TBL] [Abstract][Full Text] [Related]
9. IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expression. Li C; Rock KL; Woda BA; Jiang Z; Fraire AE; Dresser K Mod Pathol; 2007 Feb; 20(2):242-7. PubMed ID: 17192788 [TBL] [Abstract][Full Text] [Related]
10. p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations. Negri G; Egarter-Vigl E; Kasal A; Romano F; Haitel A; Mian C Am J Surg Pathol; 2003 Feb; 27(2):187-93. PubMed ID: 12548164 [TBL] [Abstract][Full Text] [Related]
11. [Expression of the protein marker p16INK4a in the cervix uteri cancer]. Volgareva GM; Zavalishina LE; Frank GA; Andreeva IuIu; Petrov AN; Kiselev FL; Spitkovskiĭ DD Arkh Patol; 2002; 64(1):22-4. PubMed ID: 11889694 [TBL] [Abstract][Full Text] [Related]
12. [Role of HPV DNA detection and p16(INK4A) protein expression in diagnosis of endocervical adenocarcinoma]. Meng ZL; Guo LN; Luo YF; Cao JL; Wan JW; Liu TH Zhonghua Bing Li Xue Za Zhi; 2007 Dec; 36(12):810-3. PubMed ID: 18346352 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia. Saqi A; Pasha TL; McGrath CM; Yu GH; Zhang P; Gupta P Diagn Cytopathol; 2002 Dec; 27(6):365-70. PubMed ID: 12451568 [TBL] [Abstract][Full Text] [Related]
14. P16 as a molecular biomarker of cervical adenocarcinoma. Schorge JO; Lea JS; Elias KJ; Rajanbabu R; Coleman RL; Miller DS; Ashfaq R Am J Obstet Gynecol; 2004 Mar; 190(3):668-73. PubMed ID: 15041997 [TBL] [Abstract][Full Text] [Related]
16. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor. Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407 [TBL] [Abstract][Full Text] [Related]
17. An analysis on the combination expression of HPV L1 capsid protein and p16INK4a in cervical lesions. Huang MZ; Li HB; Nie XM; Wu XY; Jiang XM Diagn Cytopathol; 2010 Aug; 38(8):573-8. PubMed ID: 19941368 [TBL] [Abstract][Full Text] [Related]
18. Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells. Volgareva G; Zavalishina L; Andreeva Y; Frank G; Krutikova E; Golovina D; Bliev A; Spitkovsky D; Ermilova V; Kisseljov F BMC Cancer; 2004 Aug; 4():58. PubMed ID: 15339339 [TBL] [Abstract][Full Text] [Related]
19. p16 expression in the female genital tract and its value in diagnosis. O'Neill CJ; McCluggage WG Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152 [TBL] [Abstract][Full Text] [Related]
20. P16INK4A overexpression predicts lymph node metastasis in cervical carcinomas. Huang LW; Lee CC J Clin Pathol; 2012 Feb; 65(2):117-21. PubMed ID: 22011452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]